Pharmacology
 |
|
5 february 2019 15:03:21 |
| Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors (Pharmacogenomics Journal) |
|
Tweet |
| 74 viewsCategory: Genomics, Pharmacology |
 Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? (Pharmacogenomics Journal)Precision dosing of warfarin: open questions and strategies (Pharmacogenomics Journal) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
